Does TECLISTAMAB-CQYV Cause Cardiac failure? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Cardiac failure have been filed in association with TECLISTAMAB-CQYV. This represents 0.7% of all adverse event reports for TECLISTAMAB-CQYV.
11
Reports of Cardiac failure with TECLISTAMAB-CQYV
0.7%
of all TECLISTAMAB-CQYV reports
6
Deaths
4
Hospitalizations
How Dangerous Is Cardiac failure From TECLISTAMAB-CQYV?
Of the 11 reports, 6 (54.5%) resulted in death, 4 (36.4%) required hospitalization.
Is Cardiac failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Cardiac failure?
SACUBITRIL\VALSARTAN (4,504)
FUROSEMIDE (1,841)
APIXABAN (1,575)
CYCLOPHOSPHAMIDE (1,514)
DOXORUBICIN (1,367)
ADALIMUMAB (1,278)
DEXAMETHASONE (1,271)
TREPROSTINIL (1,168)
BISOPROLOL (1,159)
LENALIDOMIDE (1,115)
Which TECLISTAMAB-CQYV Alternatives Have Lower Cardiac failure Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL